200 related articles for article (PubMed ID: 36319643)
21. FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis.
Wu C; Zheng C; Chen S; He Z; Hua H; Sun C; Yu C
Cell Death Dis; 2023 Oct; 14(10):699. PubMed ID: 37875474
[TBL] [Abstract][Full Text] [Related]
22. MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1.
Han S; Shi Y; Sun L; Liu Z; Song T; Liu Q
Int J Biol Sci; 2019; 15(13):2936-2947. PubMed ID: 31853229
[TBL] [Abstract][Full Text] [Related]
23. The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas.
Gao M; Shih IeM; Wang TL
Int J Mol Sci; 2012 Oct; 13(11):13881-93. PubMed ID: 23203039
[TBL] [Abstract][Full Text] [Related]
24. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
25. DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1.
Mitchell AV; Wu J; Meng F; Dong L; Block CJ; Song WM; Zhang B; Li J; Wu G
Cancer Res Commun; 2022 Nov; 2(11):1388-1403. PubMed ID: 36713812
[TBL] [Abstract][Full Text] [Related]
26. Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Kim SH; Hahm ER; Singh KB; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1116-1128. PubMed ID: 32754922
[TBL] [Abstract][Full Text] [Related]
27. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
28. Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells.
Kim SH; Hahm ER; Singh SV
Mol Carcinog; 2023 Oct; 62(10):1449-1459. PubMed ID: 37265428
[TBL] [Abstract][Full Text] [Related]
29. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
Sehrawat A; Kim SH; Vogt A; Singh SV
Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
[TBL] [Abstract][Full Text] [Related]
30. FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1.
Pei Y; Wang P; Liu H; He F; Ming L
Biomed Pharmacother; 2015 Aug; 74():89-94. PubMed ID: 26349968
[TBL] [Abstract][Full Text] [Related]
31. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
So CW; Cleary ML
Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
[TBL] [Abstract][Full Text] [Related]
32. Research progress on the regulation of tumor initiation and development by the forkhead box Q1 gene.
Tang H; Zhang J; Guo Q
J Cancer Res Ther; 2018 Jan; 14(1):6-11. PubMed ID: 29516951
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1.
Feng A; Yuan X; Li X
Oncol Rep; 2017 Nov; 38(5):2752-2760. PubMed ID: 29048674
[TBL] [Abstract][Full Text] [Related]
34. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
[TBL] [Abstract][Full Text] [Related]
35. FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.
Feng J; Zhang X; Zhu H; Wang X; Ni S; Huang J
PLoS One; 2012; 7(6):e39937. PubMed ID: 22761930
[TBL] [Abstract][Full Text] [Related]
36. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
37. Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
Xiao B; Liu H; Gu Z; Ji C
Arch Bronconeumol; 2016 Oct; 52(10):505-11. PubMed ID: 26858166
[TBL] [Abstract][Full Text] [Related]
38. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
39. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
40. Forkhead box Q1: A key player in the pathogenesis of tumors (Review).
Li Y; Zhang Y; Yao Z; Li S; Yin Z; Xu M
Int J Oncol; 2016 Jul; 49(1):51-8. PubMed ID: 27176124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]